Neuro-oncology Clinical Trials in New York, NY

As of June 2026, 46 paid clinical trials are recruiting for Neuro-oncology in New York, New York. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 3, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

46 clinical trials for Neuro-oncology

·Clear filters·↓ Download CSV

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

for Glioblastoma Multiforme (GBM)

1 location in New York

Sponsor: Northwell Health

Sex: All·Age: 18 - 74

Code: NCT03213002·Phase 1, Phase 2·Recruiting

Apply to this trial

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

for Glioblastoma

12 locations incl. Birmingham

Sponsor: Patrick Wen, MD

Sex: All·Age: 18+

Code: NCT02977780·Phase 2·Recruiting

Apply to this trial

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

for Glioblastoma

1 location in New York

Sponsor: Northwell Health

Sex: All·Age: 18+

Code: NCT02861898·Phase 1, Phase 2·Recruiting

Apply to this trial

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

for Glioblastoma

1 location in New York

Sponsor: Northwell Health

Sex: All·Age: 18+

Code: NCT02800486·Phase 2·Recruiting

Apply to this trial

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

for Glioblastoma Multiforme

Drug: Bevacizumab

1 location in New York

Sponsor: Northwell Health

Sex: All·Age: 18+

Code: NCT01269853·Phase 1, Phase 2·Recruiting

Apply to this trial

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

for Brain Cancer

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT00870129·Recruiting

Apply to this trial

Conditions in Neuro-oncology (New York, NY)

Glioblastoma· 22 Glioma· 18 Brain cancer· 15 Brain metastases· 5